Argenx
ARGX
#405
Rank
โ‚ฌ54.23 B
Marketcap
866,93ย โ‚ฌ
Share price
-2.76%
Change (1 day)
49.88%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total debt

Total debt on the balance sheet as of December 2025 : โ‚ฌ40.43 Million

According to Argenx 's latest financial reports the company's total debt is โ‚ฌ40.43 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Argenx - Total debt on balance sheet (from 2019 to 2020)

Total debt by year

Year Total debt Change
2013-12-31N/A-100%
2012-12-31โ‚ฌ2.23 M2.04%
2011-12-31โ‚ฌ2.19 M